Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients

AIDS

Volumn 12, Issue 15, 1998, Pages

  Walli, Ravi ^a   Herfort, Oliver ^a   Michl, Gerlinde M ^a   Demant, Thomas ^b   Jäger, Hans ^a   Dieterle, Christoph ^c   Bogner, Johannes R ^a   Landgraf, Rüdiger ^c   Goebel, Frank D ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c Kuratorium fur Immunschwache Munchen   (Germany)

Author keywords

Diabetes mellitus; HIV; Hyperlipidaemia; Impaired glucose tolerance; Insulin resistance; Metabolism; Protease inhibitors; Side effects

Indexed keywords

CHOLESTEROL; GLUCOSE; INDINAVIR; INSULIN; LIPID; PROTEINASE INHIBITOR; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIPODYSTROPHY; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032558803     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199815000-00001     Document Type: Article

References (19)

1. Carpenter CC, Fischl MA, Hammer SM, et al.: Antiretroviral therapy for HIV infection in 1997: updated recommendations of the International AIDS Society-USA panel. JAMA 1997, 277:1962-1969.
2. Moyle G, Gazzard B: Current knowledge and future prospects for the use of HIV protease inhibitors. Drugs 1996, 51:701-712.
3. McDonald CK, Kuritzkes DR: Human immunodeficiency virus type 1 protease inhibitors. Arch Intern Med 1997, 157:951-959.
4. Peng C, Ho BK, Chang TW, Chang NT: Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity. J Virol 1989, 63:2550-2556.
5. Michl G, Herfort O, Walli R, Anders HJ, Jacob K, Goebel FD: Incidence and risk factors of crystalluria in patients treated with indinavir. Sixth European Conference on Clinical Aspects and Treatment of HIV Infection. Hamburg, October 1997 [abstract 442].
6. Kopp JB, Miller KD, Mican JA, et al.: Crystalluria and urinary tract abnormalities associated with indinavir. Ann intern Med 1997, 127:119-125.
7. Ault A: FDA warns of potential protease-inhibitor link to hyperglycaemia [news]. Lancet 1997, 349:1819.
8. Dubé MP, Johnson DL, Currier JS, Leedom JM: Protease inhibitor-associated hyperglycaemia [letter]. Lancet 1997, 350:713-714.
9. Eastone JA, Decker CF: New-onset diabetes mellitus associated with use of protease inhibitor. Ann Intern Med 1997, 127:947.
10. Carr A, Samaras K, Burton S, Freund J, Chisholm DJ, Cooper DA: A syndrome of peripheral lipodystrophy, hyperlipidemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998, 12:F51-F58.
11. Hengel RL, Watts NB, Lennox JL: Benign symmetric lipomatosis associated with protease inhibitors [letter]. Lancet 1997, 350:1596.
12. Jimenez-Expósito MJ, Paul A, Laville A, Masana L: Non activity of hepatic lipase during treatment with ritonavir. Sixth European Conference on Clinical Aspects and Treatment of HIV Infection. Hamburg, October 1997 [abstract 733].
13. Keen H, Barnes DJ: The diagnosis and classification of diabetes mellitus and impaired glucose tolerance. In Textbook of Diabetes. Edited by Pickup JC, Williams G. London: Blackwell Science; 1996.
14. Gelding SV, Robinson S, Lowe S, Niththyananthan R, Johnston DG: Validation of the low dose short insulin tolerance test for evaluation of insulin sensitivity. Clin Endocrinol (Oxf) 1994, 40:611-615.
15. Gelding SV, Niththyananthan R, Chan SP, et al.: Insulin sensitivity in non-diabetic relatives of patients with non-insulin-dependent diabetes from two ethnic groups. Clin Endocrinol (Oxf) 1994, 40:55-62.
16. McKeigue PM, Pierpoint T, Ferrie JE, Marmot MG: Relationship of glucose intolerance and hyperinsulinaemia to body fat pattern in south Asians and Europeans. Diabetologia 1992, 35:785-791.
17. WHO: Diabetes mellitus. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1985, 727:10-11.
18. Rosner B: Fundamentals of Biostatistics, 3rd Edn. Boston: PWS-Kent Publishing; 1990.
19. Syvanne M, Taskinen M: Lipids and lipoproteins as coronary risk factors in non-insulin-dependant diabetes mellitus. Lancet 1997, 350 (suppl 1):S120-S123.